FDA's New GRAS Rule Would Force Ingredient Notices, Not Safety Reviews

The Food and Drug Administration is trying to turn a long-running food-ingredient blind spot into a mandatory disclosure system, but the proposal stops short of making every new additive wait for FDA approval before it reaches grocery shelves.

HHS announced on August 10, 2026, that FDA had proposed a rule requiring manufacturers to notify the agency when they conclude that a substance added to human or animal food is generally recognized as safe, or GRAS. The Federal Register notice was published August 11, and public comments are due by December 9, 2026.

What would change

Under the current system, companies can determine on their own that an ingredient is GRAS under its intended conditions of use. They may notify the FDA, but they do not have to. FDA says the proposed rule would convert that voluntary notification program into a mandatory one for certain uses of substances in human and animal food.

The practical change is visibility. Companies using the GRAS pathway would have to submit the basis for their safety conclusion, and FDA says the information would help the agency and the public see more of what is entering the food supply. HHS also says substances already on the market through self-GRAS conclusions would get a time-limited, streamlined submission option.

What it would not do

The proposal would not turn every GRAS ingredient into a full premarket approval application. AP reported that FDA officials said mandatory safety reviews would require action from Congress. That means the rule is better understood as a disclosure and oversight proposal, not an immediate ban or blanket reapproval of thousands of ingredients already in packaged foods.

That distinction matters for consumers. A public list of submitted ingredients could make the system easier to inspect, but inclusion on that list would not necessarily mean the FDA has independently endorsed an ingredient as safe. Former FDA food-program director Susan Mayne told AP that the rule could give regulators a clearer market inventory while still leaving most self-affirmed GRAS ingredients outside full FDA safety review.

Why it matters now

The rule is part of a broader HHS and USDA food-policy push that also includes a proposed federal definition of ultra-processed foods, which HHS says has been submitted for final review. HHS cited ultra-processed foods' large share of the American diet and links between high consumption and chronic disease as reasons for stronger nutrition-policy infrastructure.

Food companies, consumer groups and public-health researchers are likely to focus on the same unresolved question during the comment period: whether mandatory notice is enough. Supporters can argue that FDA cannot police risks it cannot see. Critics can argue that disclosure without required independent review still leaves too much responsibility in company hands.

What to watch

The next concrete deadline is December 9, 2026, when the comment period closes. After that, FDA would have to review the record before issuing any final rule. The larger question is whether Congress gives the agency more explicit power to require premarket reviews for a wider set of food ingredients.

For shoppers, the rule would not immediately change labels or make a packaged food safer overnight. Its main effect would be upstream: more mandatory paperwork, a larger public inventory and a clearer path for FDA to spot ingredients that may need closer scrutiny.